Ciluprevir

Ciluprevir

SCHEMBL5152276

COc1ccc2c(OC3CC4C(=O)NC5(C(=O)O)CC5C=CCCCCCC(NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(C)C)n3)nc2c1

nearest known ligand 0.75

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

NS3NS4A

The experimentally established mechanism targets of Ciluprevir. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ ADRB3 P13945 1/20 0.75
▸ ADRA2B P18089 1/20 0.75
▸ ADRA2C P18825 1/20 0.75
▸ CTSB P07858 2/20 0.45
▸ CTSS P25774 1/20 0.38
▸ PPP3CB P16298 1/20 0.38
▸ ABCC1 P33527 1/20 0.34
▸ ABCC2 Q92887 1/20 0.34
▸ ABCG2 Q9UNQ0 1/20 0.34
▸ CYP3A4 P08684 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ciluprevir SCHEMBL1735179 1.00 ADRB3 (0.75) ADRB3ADRA2BADRA2CCTSBCTSS
Ciluprevir SCHEMBL1736294 1.00 ADRB3 (0.75) ADRB3ADRA2BADRA2CCTSBCTSS
Ciluprevir SCHEMBL12300089 1.00 ADRB3 (0.75) ADRB3ADRA2BADRA2CCTSBCTSS
Ciluprevir SCHEMBL16199312 1.00 ADRB3 (0.75) ADRB3ADRA2BADRA2CCTSBCTSS
Ciluprevir SCHEMBL18671856 1.00 ADRB3 (0.75) ADRB3ADRA2BADRA2CCTSBCTSS
Ciluprevir SCHEMBL5152261 1.00 ADRB3 (0.75) ADRB3ADRA2BADRA2CCTSBCTSS
Ciluprevir SCHEMBL16438974 1.00 ADRB3 (0.75) ADRB3ADRA2BADRA2CCTSBCTSS
Ciluprevir SCHEMBL2524642 1.00 ADRB3 (0.75) ADRB3ADRA2BADRA2CCTSBCTSS
SCHEMBL13915576 0.96 ADRB3 (0.70) ADRB3ADRA2BADRA2CCTSBCTSS
SCHEMBL12154816 0.96 ADRB3 (0.69) ADRB3ADRA2BADRA2CCTSBCTSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1799194-A2 A NEW CLASS OF SURFACTANT-LIKE MATERIALS COMPRISING VITAMIN E TPGS AND A WATER SOLUBLE POLYMER BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 2007-06-27 — — EP disclosed
WO-2006036614-A2 A NEW CLASS OF SURFACTANT-LIKE MATERIALS COMPRISING VITAMIN E TPGS AND A WATER SOLUBLE POLYMER BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2006-04-06 — — WO disclosed
Send feedback